Benzinga's Top Downgrades By: Benzinga via Benzinga April 26, 2016 at 09:14 AM EDT Analysts at Piper Jaffray downgraded Sarepta Therapeutics Inc (NASDAQ: SRPT) from Neutral to Underweight. The target price for Sarepta ... Read More >> Related Stocks: Canadian National Railway Company Sarepta Therapeutics U.S. Bancorp Zions Bancorp